Scatter in repolarization timing predicts clinical events in post-myocardial infarction patients.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 2330016)

Published in Heart Rhythm on October 06, 2007

Authors

Nathan M Segerson1, Sheldon E Litwin, Marcos Daccarett, T Scott Wall, Mohamed H Hamdan, Robert L Lux

Author Affiliations

1: University of Utah School of Medicine, Department of Internal Medicine, Division of Cardiology, Salt Lake City, Utah, USA. Nathan.Segerson@hsc.utah.edu

Articles cited by this

Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J (1996) 16.86

Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. JAMA (2002) 5.19

Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation (2004) 3.12

Action potential duration restitution and alternans in rabbit ventricular myocytes: the key role of intracellular calcium cycling. Circ Res (2005) 2.89

Nerve sprouting and sudden cardiac death. Circ Res (2000) 2.80

Role of calcium cycling versus restitution in the mechanism of repolarization alternans. Circ Res (2004) 2.80

Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue. Circulation (2000) 2.73

Electrical alternans and spiral wave breakup in cardiac tissue. Chaos (1994) 2.60

Correlation between in vivo transmembrane action potential durations and activation-recovery intervals from electrograms. Effects of interventions that alter repolarization time. Circulation (1990) 2.55

Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy. Circulation (1997) 2.53

Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol (2006) 2.34

Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol (2005) 2.29

Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol (1998) 2.25

Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs. Circulation (2004) 2.09

Incidence of EMS-treated out-of-hospital cardiac arrest in the United States. Resuscitation (2004) 2.02

A study of the factors responsible for rate-dependent shortening of the action potential in mammalian ventricular muscle. J Physiol (1978) 1.99

Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res (2000) 1.97

Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol (2006) 1.96

Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J (1992) 1.91

Analysis of the effects of changes in rate and rhythm upon electrical activity in the heart. Prog Biophys Mol Biol (1980) 1.85

Spatial dispersion of action potential duration restitution kinetics is associated with induction of ventricular tachycardia/fibrillation in humans. J Cardiovasc Electrophysiol (2004) 1.84

Increased ventricular repolarization heterogeneity in patients with ventricular arrhythmia vulnerability and cardiomyopathy: a human in vivo study. Am J Physiol Heart Circ Physiol (2005) 1.78

Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res (2001) 1.70

Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death. Cardiovasc Res (2003) 1.64

Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations. Circulation (2000) 1.58

QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study. Eur Heart J (2006) 1.39

Restitution of the action potential in cat papillary muscle. Am J Physiol (1975) 1.34

Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes. J Am Coll Cardiol (2006) 1.25

Fluctuations in T-wave morphology and susceptibility to ventricular fibrillation. J Electrocardiol (1984) 1.24

Limited lead selection for estimation of body surface potential maps in electrocardiography. IEEE Trans Biomed Eng (1978) 1.23

Autonomic nerve stimulation reverses ventricular repolarization sequence in rabbit hearts. Circ Res (2007) 1.22

Dispersion of refractoriness in canine ventricular myocardium. Effects of sympathetic stimulation. Circ Res (1991) 1.19

Estimates of repolarization dispersion from electrocardiographic measurements. Circulation (2000) 1.12

Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Cardiovasc Res (2006) 1.12

Dynamic analysis of cardiac R-R intervals in normal infants and in infants who subsequently succumbed to the sudden infant death syndrome. Pediatr Res (1992) 1.01

Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol (1997) 0.98

Estimates of repolarization and its dispersion from electrocardiographic measurements: direct epicardial assessment in the canine heart. J Electrocardiol (2000) 0.90

Dispersion of refractoriness in normal and ischaemic canine ventricle: effects of sympathetic stimulation. Cardiovasc Res (1993) 0.87

The autonomic control of the transmural dispersion of ventricular repolarization in anesthetized dogs. J Cardiovasc Electrophysiol (1999) 0.86

Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal. Am Heart J (2007) 0.85

Dynamic characteristics of cardiac R-R intervals during sleep and waking states. Sleep (1991) 0.84

Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy. Am J Cardiol (2002) 0.83

Noninvasive indices of repolarization and its dispersion. J Electrocardiol (1999) 0.82

Cardiac arrhythmias: the quest for a cure: a historical perspective. J Am Coll Cardiol (2004) 0.80

The dispersion of repolarization in patients with ventricular tachycardia. A study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J (1995) 0.80

Scatterplots of RR and RT interval variability bring evidence for diverse non-linear dynamics of heart rate and ventricular repolarization duration in coronary heart disease. Europace (2001) 0.77

Abnormal intracellular calcium handling underlying T-wave alternans and its hysteresis. Cardiology (2006) 0.76

Analysis of beat-to-beat heart rate changes during sleep-waking states in normal infants. J Dev Physiol (1993) 0.76

Articles by these authors

Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation (2009) 4.33

New magnetic resonance imaging-based method for defining the extent of left atrial wall injury after the ablation of atrial fibrillation. J Am Coll Cardiol (2008) 3.67

Atrial fibrosis helps select the appropriate patient and strategy in catheter ablation of atrial fibrillation: a DE-MRI guided approach. J Cardiovasc Electrophysiol (2010) 3.18

Health benefits of gastric bypass surgery after 6 years. JAMA (2012) 3.10

Cardiac remodeling in obesity. Physiol Rev (2008) 2.95

Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol (2006) 2.86

Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol (2003) 2.57

Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest (2002) 2.53

Left ventricular hypertrophy in severe obesity: interactions among blood pressure, nocturnal hypoxemia, and body mass. Hypertension (2006) 2.43

Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology (2005) 2.43

Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation. Heart Rhythm (2010) 2.42

Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging (2010) 2.36

Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. JACC Cardiovasc Imaging (2016) 2.36

Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol (2011) 2.26

Disruption of the circadian clock within the cardiomyocyte influences myocardial contractile function, metabolism, and gene expression. Am J Physiol Heart Circ Physiol (2007) 2.17

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 2.13

Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol (2005) 2.12

Improved heart rate recovery after marked weight loss induced by gastric bypass surgery: two-year follow up in the Utah Obesity Study. Heart Rhythm (2010) 2.06

Feasibility and safety of same-day discharge after implantable cardioverter defibrillator placement for primary prevention. Pacing Clin Electrophysiol (2013) 1.99

Which measures of obesity best predict cardiovascular risk? J Am Coll Cardiol (2008) 1.94

Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation (2009) 1.91

Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension (2009) 1.78

Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J Cardiovasc Electrophysiol (2007) 1.73

Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metab (2008) 1.65

Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes (2008) 1.55

Heart rate turbulence parameters correlate with post-premature ventricular contraction changes in muscle sympathetic activity. Heart Rhythm (2006) 1.54

Dark regions of no-reflow on late gadolinium enhancement magnetic resonance imaging result in scar formation after atrial fibrillation ablation. J Am Coll Cardiol (2011) 1.53

A protocol for patients with cardiovascular implantable devices undergoing magnetic resonance imaging (MRI): should defibrillation threshold testing be performed post-(MRI). J Interv Card Electrophysiol (2010) 1.53

Evaluation of left atrial lesions after initial and repeat atrial fibrillation ablation: lessons learned from delayed-enhancement MRI in repeat ablation procedures. Circ Arrhythm Electrophysiol (2010) 1.52

Quercetin reduces blood pressure in hypertensive subjects. J Nutr (2007) 1.51

Sleep apnea: from the nose to the heart. J Am Board Fam Pract (2002) 1.49

High-frequency ventricular ectopy can increase sympathetic neural activity in humans. Heart Rhythm (2010) 1.46

Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension. J Cardiovasc Electrophysiol (2012) 1.43

A conserved role for phosphatidylinositol 3-kinase but not Akt signaling in mitochondrial adaptations that accompany physiological cardiac hypertrophy. Cell Metab (2007) 1.42

Sympathoexcitation is attenuated during low level lower body negative pressure in subjects who develop pre-syncope. Clin Auton Res (2003) 1.40

Mechanisms of exercise intolerance: insights from tissue Doppler imaging. Circulation (2004) 1.40

Real-time magnetic resonance imaging-guided radiofrequency atrial ablation and visualization of lesion formation at 3 Tesla. Heart Rhythm (2010) 1.37

Magnetic resonance imaging-confirmed ablative debulking of the left atrial posterior wall and septum for treatment of persistent atrial fibrillation: rationale and initial experience. J Cardiovasc Electrophysiol (2009) 1.36

Case report: Radiofrequency catheter ablation of typical atrial flutter and the atrioventricular junction via the superior vena caval approach in a patient with a congenital absence of an inferior vena cava. J Interv Card Electrophysiol (2006) 1.33

Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol (2008) 1.33

PGC-1β deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ Res (2011) 1.31

Health outcomes of gastric bypass patients compared to nonsurgical, nonintervened severely obese. Obesity (Silver Spring) (2009) 1.29

Effect of atrial fibrillation and an irregular ventricular response on sympathetic nerve activity in human subjects. Circulation (2003) 1.25

Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy. Cardiovasc Res (2013) 1.25

Temporal left atrial lesion formation after ablation of atrial fibrillation. Heart Rhythm (2008) 1.23

Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology (2007) 1.14

Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol (2009) 1.12

Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J Mol Cell Cardiol (2009) 1.09

Inadvertent placement of pacemaker lead into the systemic ventricle in repaired D-transposition of the great arteries. Circulation (2010) 1.08

Estimated body surface potential maps in emergency department patients with unrecognized transient myocardial ischemia. J Electrocardiol (2007) 1.07

Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction. Am J Physiol Heart Circ Physiol (2012) 1.06

Quercetin-supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J Cardiovasc Pharmacol (2006) 1.05

Focal myocardial infarction induces global remodeling of cardiac sympathetic innervation: neural remodeling in a spatial context. Am J Physiol Heart Circ Physiol (2013) 1.05

Spatial methods of epicardial activation time determination in normal hearts. Ann Biomed Eng (2003) 1.04

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study. Int J Cardiovasc Imaging (2011) 1.04

Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. J Mol Cell Cardiol (2005) 1.03

Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study. Crit Ultrasound J (2012) 1.02

A quercetin supplemented diet does not prevent cardiovascular complications in spontaneously hypertensive rats. J Nutr (2007) 0.99

Mechanistic target of rapamycin (Mtor) is essential for murine embryonic heart development and growth. PLoS One (2013) 0.99

The prevalence and cost of the faint and fall problem in the state of Utah. Pacing Clin Electrophysiol (2010) 0.98

Integrin activation in the heart: a link between electrical and contractile dysfunction? Circ Res (2006) 0.98

Effect of Terplex/VEGF-165 gene therapy on left ventricular function and structure following myocardial infarction. VEGF gene therapy for myocardial infarction. J Control Release (2003) 0.98

Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol (2008) 0.98

Arrhythmogenic right ventricular cardiomyopathy without fatty infiltration. J Cardiovasc Electrophysiol (2004) 0.96

Back to the future: the role of the autonomic nervous system in atrial fibrillation. Pacing Clin Electrophysiol (2006) 0.96

The effects of rate and irregularity on sympathetic nerve activity in human subjects. Heart Rhythm (2006) 0.95

Modulation of regional dispersion of repolarization and T-peak to T-end interval by the right and left stellate ganglia. Am J Physiol Heart Circ Physiol (2013) 0.92

A novel technique for right ventricular lead placement in a patient with a persistent left superior vena cava. Europace (2007) 0.92

New concepts in the assessment of syncope. J Am Coll Cardiol (2012) 0.91

Irregular ventricular activation results in QT prolongation and increased QT dispersion: a new insight into the mechanism of AF-induced ventricular arrhythmogenesis. J Cardiovasc Electrophysiol (2011) 0.91

Functional differences between junctional and extrajunctional adrenergic receptor activation in mammalian ventricle. Am J Physiol Heart Circ Physiol (2012) 0.90

A novel double cryoballoon strategy in persistent atrial fibrillation: a pilot study. Clin Res Cardiol (2012) 0.90

Hereditary Hemorrhagic Telangiectasia Presenting as High Output Cardiac Failure during Pregnancy. Cardiol Res Pract (2009) 0.89

Syncope in the emergency department: comparison of standardized admission criteria with clinical practice. Europace (2011) 0.89

Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. J Mol Cell Cardiol (2012) 0.89

The growing problem of obesity and the heart: the plot "thickens". J Am Coll Cardiol (2006) 0.88

Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload. Am J Physiol Heart Circ Physiol (2010) 0.87

The associations between tricuspid annular plane systolic excursion (TAPSE), ventricular dyssynchrony, and ventricular interaction in heart failure patients. Eur J Echocardiogr (2008) 0.87

Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. J Med Microbiol (2006) 0.86

Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation? Am J Cardiol (2010) 0.86

Intracardiac echocardiography improves procedural efficiency during cryoballoon ablation for atrial fibrillation: a pilot study. J Cardiovasc Electrophysiol (2010) 0.85

Reductions in cardiovascular risk after bariatric surgery. Curr Opin Cardiol (2011) 0.85

Noninvasive assessment of pulmonary artery pressures: moving beyond tricuspid regurgitation velocities. Circ Cardiovasc Imaging (2010) 0.85

Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation (2002) 0.85

Modulation of the sinus rate during ventricular fibrillation. J Cardiovasc Electrophysiol (2009) 0.85

Evolving cardiac conduction phenotypes in developing zebrafish larvae: implications to drug sensitivity. Zebrafish (2010) 0.85

PKC translocation and ERK1/2 activation in compensated right ventricular hypertrophy secondary to chronic emphysema. BMC Physiol (2005) 0.84

Dynamic tracking of ischemia in the surface electrocardiogram. J Electrocardiol (2007) 0.84

Experimental measures of ventricular activation and synchrony. Pacing Clin Electrophysiol (2008) 0.84

Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol (2007) 0.84

Permanent pacemaker implantation following aortic valve replacement: current prevalence and clinical predictors. Pacing Clin Electrophysiol (2009) 0.84

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol (2017) 0.83

Klebsiella pneumoniae: a rare cause of device-associated endocarditis. Pacing Clin Electrophysiol (2006) 0.83

Standardized care pathway versus conventional approach in the management of patients presenting with faint at the University of Utah. Pacing Clin Electrophysiol (2012) 0.83